Hoberman Kenneth Insider Trades

Insider Trading History

Track insider trading activity for Hoberman Kenneth. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $3.08M 168,140 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$368k 35,000 shares
$10.51
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $470k 8,325 shares
Last Trade
Jun 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 8,325 shares
$48.05
$56.41
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $2.44M 133,140 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 30,000 shares
$8.83
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $15.8M 279,653 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$550k 14,718 shares
$37.37
$56.41
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $0 0 shares
Last Trade
Jul 19, 2024 Sale
$65.5k 9,750 shares
$6.72
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $14.9M 264,935 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373k 22,250 shares
$16.77
$56.41
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $1.89M 103,140 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 30,000 shares
$6.83
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $13.7M 242,685 shares
Last Trade
Sep 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 20,000 shares
$8.77
$56.41
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $1.34M 73,140 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 18,000 shares
$18.10
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $12.6M 222,685 shares
Last Trade
Jul 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$300k 43,732 shares
$6.86
$56.41
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $1.01M 55,140 shares
Last Trade
May 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$104k 6,000 shares
$17.40
$18.29
Nuvectis Pharma
Nuvectis Pharma NVCT
Director
Holding Value $274k 15,000 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$105k 15,000 shares
$7.02
$18.29
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $10.1M 178,953 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$751k 20,000 shares
$37.56
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $8.97M 158,953 shares
Last Trade
Jun 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$298k 15,000 shares
$19.84
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $8.12M 143,953 shares
Last Trade
Sep 17, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 27,048 shares
$6.47
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $6.59M 116,905 shares
Last Trade
Jun 26, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$199k 15,000 shares
$13.25
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $5.75M 101,905 shares
Last Trade
Jun 16, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$167k 15,000 shares
$11.10
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $4.9M 86,905 shares
Last Trade
Jul 06, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75k 12,459 shares
$6.02
$56.41
TG Therapeutics
TG Therapeutics TGTX
Director
Holding Value $4.2M 74,446 shares
Last Trade
Jun 04, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75k 4,667 shares
$16.07
$56.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up